Oelschlager Kristen M — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Oelschlager Kristen M has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $778K.

Profile

Oelschlager Kristen M

Kristen M. Oelschlager is the Chief Operating Officer at Castle Biosciences Inc, a molecular diagnostics company specializing in tests for dermatologic cancers and other conditions. She has been involved in the company's operations and strategic initiatives, contributing to its growth in the diagnostics field.

RoleChief Operating Officer
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06CSTLCASTLE BIOSCIENCES INCS — Open-market sale400$24.78$10K
2026-07-06CSTLCASTLE BIOSCIENCES INCS — Open-market sale8.2K$24.40$200K
2026-06-18CSTLCASTLE BIOSCIENCES INCS — Open-market sale8.6K$20.71$178K
2026-03-05CSTLCASTLE BIOSCIENCES INCF — Tax withholding / forfeiture6.8K$28.17$191K
2026-03-05CSTLCASTLE BIOSCIENCES INCM — Option exercise25.8K—
2026-03-05CSTLCASTLE BIOSCIENCES INCF — Tax withholding / forfeiture2.4K$27.57$67K
2026-01-14CSTLCASTLE BIOSCIENCES INCA — Grant or award9.2K$0.00
2025-08-27CSTLCASTLE BIOSCIENCES INCS — Open-market sale18.0K$21.69$391K
2025-08-08CSTLCASTLE BIOSCIENCES INCF — Tax withholding / forfeiture2.8K$19.36$54K
2025-08-08CSTLCASTLE BIOSCIENCES INCM — Option exercise10.6K$0.00
2024-12-11CSTLCASTLE BIOSCIENCES INCF — Tax withholding / forfeiture1.6K$29.63$48K
2024-12-11CSTLCASTLE BIOSCIENCES INCM — Option exercise6.2K—
2024-12-11CSTLCASTLE BIOSCIENCES INCF — Tax withholding / forfeiture530$29.63$16K
2024-12-11CSTLCASTLE BIOSCIENCES INCM — Option exercise1.8K—
2024-12-11CSTLCASTLE BIOSCIENCES INCF — Tax withholding / forfeiture4.2K$30.91$130K
2024-12-11CSTLCASTLE BIOSCIENCES INCM — Option exercise16.0K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Oelschlager Kristen M?

Kristen M. Oelschlager is the Chief Operating Officer at Castle Biosciences Inc, a molecular diagnostics company specializing in tests for dermatologic cancers and other conditions. She has been involved in the company's operations and strategic initiatives, contributing to its growth in the diagnostics field.…

How many SEC Form 4 filings has Oelschlager Kristen M submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Oelschlager Kristen M been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 4 open-market sales ($778K) across all tracked filings.

Where can I see all of Oelschlager Kristen M's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Oelschlager Kristen M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.